Literature DB >> 9435341

Cloning and mapping of cat (Felis catus) immunoglobulin and T-cell receptor genes.

K Cho1, H Y Youn, M Okuda, H Satoh, S Cevario, S J O'Brien, T Watari, H Tsujimoto, A Hasegawa.   

Abstract

Molecular cloning and chromosomal mapping of the cat immunoglobulin (Ig) and T-cell receptor (TcR) genes were carried out to provide basic information for genetic analysis of immunologic diseases including leukemias and lymphomas in cats. We cloned two Ig constant genes, IGHM and IGHG and three TcR constant genes, TRAC, TRGC, and TRDC, by polymerase chain reaction (PCR) amplification of cDNA from cat peripheral blood mononuclear cells. For chromosomal mapping of the Ig and TcR loci including the IGK, IGL, and TRB on the cat genome, we performed PCR screening of DNAs from 37 cat x rodent somatic cell hybrids by using specific primers for the given genes. Consequently, three loci for IGH, TRA, and TRD, and two loci for TRB and TRG were found to be syntenic and assigned to cat chromosomes (FCA) B3 and A2, respectively. Further, IGK and IGL loci were mapped on FCA A3 and D3, respectively. These findings support the notion that the genetic linkages between the Ig and TcR genes are extensively conserved between humans and cats.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9435341     DOI: 10.1007/s002510050352

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  2 in total

1.  Molecular characterization of the feline T-cell receptor γ alternate reading frame protein (TARP) ortholog.

Authors:  Alexander Th A Weiss; Marie-Charlotte von Deetzen; Werner Hecht; Manfred Reinacher; Achim D Gruber
Journal:  J Vet Sci       Date:  2012-12       Impact factor: 1.672

2.  Sequence analysis of feline immunoglobulin mRNAs and the development of a felinized monoclonal antibody specific to feline panleukopenia virus.

Authors:  Zhengchun Lu; Rebecca L Tallmadge; Heather M Callaway; M Julia B Felippe; John S L Parker
Journal:  Sci Rep       Date:  2017-10-05       Impact factor: 4.379

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.